Literature DB >> 11897564

Activation of hepatic stellate cells--a key issue in liver fibrosis.

Helen L Reeves1, Scott L Friedman.   

Abstract

Hepatic fibrosis describes the presence of excess collagen due to new fiber formation, laid down as part of the tissue repair response to chronic liver injury. The causes of injury include toxins, disorders of the immune system, viral and parasitic infections, as well as rarer liver diseases such as haemochromatosis, Wilson's disease and galactosaemia. Whatever the cause of injury, the cells and soluble factors contributing to this wound healing response are similar. The principal effector of hepatic fibrogenesis is now widely recognized as the hepatic stellate cell. Stellate cells are usually quiescent cells, but in response to liver injury they undergo an activation process in which they become highly proliferative and synthesize a fibrotic matrix rich in type I collagen. Initiation of stellate cell activation is largely due to paracrine stimulation, whereas perpetuation of activation involves autocrine as well as paracrine loops, and is dependent on a number of functional changes. The principal paracrine and autocrine factors currently thought to be involved in these processes are discussed in this review, as are the roles of the extracellular matrix, the nuclear receptor superfamily, non-peptide ligands, and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897564     DOI: 10.2741/reeves

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  142 in total

1.  Effects of herbal compound 861 on human hepatic stellate cell proliferation and activation.

Authors:  Lin Wang; Jian Wang; Bao-En Wang; Pei-Gen Xiao; Yan-Jiang Qiao; Xue-Hai Tan
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

2.  Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: implication in tissue fibrosis.

Authors:  Lan Qin; Yuan-Ping Han
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

3.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

4.  Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule.

Authors:  Sandra March; Mariona Graupera; María Rosa Sarrias; Francisco Lozano; Pilar Pizcueta; Jaume Bosch; Pablo Engel
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

5.  Hepatic stimulator substance alleviates toxin-induced and immune-mediated liver injury and fibrosis in rats.

Authors:  Xuerui Yi; Ming Song; Youcheng Yuan; Xinrui Zhang; Wenyin Chen; Jin Li; Minghua Tong; Guangze Liu; Song You; Xiangping Kong
Journal:  Dig Dis Sci       Date:  2012-04-27       Impact factor: 3.199

6.  Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse.

Authors:  Alisan Kahraman; Justin L Mott; Steven F Bronk; Nathan W Werneburg; Fernando J Barreyro; Maria E Guicciardi; Yuko Akazawa; Karen Braley; Ruth W Craig; Gregory J Gores
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

7.  Regulation of granuloma fibrosis by nitric oxide during Mycobacterium avium experimental infection.

Authors:  Susana Lousada; Manuela Flórido; Rui Appelberg
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

8.  Kangxian ruangan keli inhibits hepatic stellate cell proliferation mediated by PDGF.

Authors:  Ling Yang; Chi-Zhi Zhang; Qing-Jing Zhu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

9.  Differential hepatoprotective mechanisms of rutin and quercetin in CCl(4)-intoxicated BALB/cN mice.

Authors:  Robert Domitrović; Hrvoje Jakovac; Vanja Vasiljev Marchesi; Sanda Vladimir-Knežević; Olga Cvijanović; Zarko Tadić; Zeljko Romić; Dario Rahelić
Journal:  Acta Pharmacol Sin       Date:  2012-08-20       Impact factor: 6.150

Review 10.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.